Furthermore, combination therapy with 673A and the DSB repair pathway inhibitors, AZD1390 (ATM) and AZD6738 (ATR), resulted in a synergistic killing ovarian cancer cell lines. The gene discussed is ATR; the disease is ovarian cancer.